Intelligent Bio Solutions Inc. (INBS) stock
INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3057% below fair value
$1.56+0.06 (+4.00%)
Close on Nov 17, 2026Market cap $4.72MP/E –Yield –
Intelligent Bio Solutions price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Intelligent Bio Solutions's price to sales ratio was 1.4× on Nov 11, 2026, against 1.8× a year earlier. Over the last 5 years it ranged from 0.2× to 145.1×, with a median of 2.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.4× | −1.2 |
| 2025 | Dec 31, 2025 | 2.6× | +0.6 |
| 2024 | Dec 31, 2024 | 2.0× | +1.6 |
| 2023 | Dec 29, 2023 | 0.4× | −3.6 |
| 2022 | Dec 30, 2022 | 4.0× | −10.0 |
| 2021 | Oct 29, 2021 | 14.0× | – |
See a number that looks wrong?